KHKryštof Haratek

Kryštof Haratek

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Kryštof Haratek has a total of 27 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • A More Precise Description of the AKT2 ‐Related Hypoinsulinemic Hypoglycemia and Overgrowth Syndrome Phenotype, Formerly Described Under the MORFAN Acronym

    by Marek Turnovec, Adéla Bubeníková, OndřEj Rýdlo, Petr Skalický, Michal Zápotocký, Kryštof Haratek, Karolina Kočandrlová, Milan Macek, Vladimír Beneš, OndřEj Bradáč, et al.

    The AKT2‐related hypoinsulinemic hypoglycemia and overgrowth syndrome was initially described over 30 years ago as MORFAN syndrome which was an acronym for Mental retardation, pre‐ and post‐natal Overgrowth, Remarkable Face, and Acanthosis Nigricans. Despite the limited possibility of confirming a diagnosis on the molecular level at that time, a comprehensive 30‐year follow‐up of a patient facilitated a detailed exploration of the syndrome's clinical trajectory. This article presents a case report spanning three decades, highlighting the significance of detailed clinical follow‐up in understanding and studying this unique syndrome. Although initially associated with intellectual deficiency, the patient's intellectual abilities remain largely within the normal range. Neuropsychological examinations revealed selective neurocognitive impairment, with a predominant disruption in psychomotor speed and executive functions. Molecular genetic examination confirmed a pathogenic variant in the AKT2 gene, associated with impaired insulin metabolism and increased tumorigenesis risk. Neurooncological assessments revealed intracranial meningiomatosis, emphasizing the syndrome's potential oncological implications. Surgical interventions addressed various complications, including meningiomas and renal hamartomas. The presented case offers valuable insights into the long‐term natural history of AKT2‐related hypoinsulinemic hypoglycemia and overgrowth syndrome, suggesting the importance of regular oncological surveillance due to its predisposition to tumorigenesis, thereby providing clinical considerations for future cases based on long‐term follow‐up experience.

  • Long-term prognosis and treatment outcomes in infantile and neonatal brain tumors

    by Adéla Bubeníková, Kryštof Haratek, Jana Táborská, Kateřina Trková, David Sumerauer, Martin Kynčl, Lenka Krsková, Miroslav Koblížek, Josef Zámečník, Petr Libý, et al.

    Purpose The specifics of biological behavior, anatomical localization, treatment, decision-making, and long-term prognosis in neonatal and infantile intracranial tumors have not been well studied. Methods A retrospective monocentric study of patients aged ≤ 12 months treated for an intracranial tumor over a 23-year period was performed. Data regarding the survival rate according to the tumor histology were evaluated in further detail. Results A total of 63 patients with a median age of 200 days at the first admission (interquartile range (IQR) = 118–301 days) were analyzed. Most tumors were supratentorial (67.7%). Overall survival according to histopathological subgroups of included tumors was the most favorable in the low-grade glioma subgroup with 1- and 3-year survival of 96% (95% confidence interval [CI] = 88.6–100%) and 88% (95% CI = 76.1–100%), while the 3-year survival for the embryonal tumors subgroup was 15% (95% CI = 4.2–53.4%). Mortality in the cohort reached 42.8% with the median time to death of 6 months (IQR = 1–12 months). Conclusion Infantile and neonatal primary CNS tumors significantly vary from CNS tumors in older pediatric patients both in their localization, distribution of histopathological subtypes, and the presence of mutations specific to these tumors, providing useful therapeutic targets. Brain tumors in children under 1 year of age are scarce compared to other pediatric brain tumors.


  • Clinical Improvement after Shunt Surgery in Patients with Idiopathic Normal Pressure Hydrocephalus Can Be Quantified by Diffusion Tensor Imaging

    by Adéla Bubeníková, Vojtěch Sedlák, Petr Skalický, Ondřej Rýdlo, Kryštof Haratek, Aleš Vlasák, Róbert Leško, David Netuka, Vladimír Beneš, Ondřej Bradáč

    BACKGROUND AND PURPOSE: White matter changes assessed by DTI typically reflect tract functionality. This study aimed to investigate DTI parameter alterations in important regions pre- and postshunt implantation in patients with idiopathic normal pressure hydrocephalus (iNPH), alongside assessing the relationship between DTI parameters and clinical improvement. MATERIALS AND METHODS: Patients with probable iNPH underwent prospective preoperative MRI and comprehensive clinical work-up between 2017–2022. Patients with clinical symptoms of iNPH, positive result on a lumbar infusion test, and/or gait improvement after 120-hour lumbar drainage were diagnosed with iNPH and underwent shunt-placement surgery. Fractional anisotropy and mean diffusivity values for individual regions of interest were extracted from preoperative and postoperative MRI. These values were correlated with the clinical picture of individual patients. RESULTS: A total of 32 patients (73.59 ± 4.59 years) with definite iNPH were analyzed. Preoperative DTI characteristics of internal capsule and corona radiata correlated with the 1-year improvement in the Dutch Gait Scale postoperatively (all P < .036). Cognitive domain improvement after surgery in memory and psychomotor speed correlated with preoperative DTI values of cingulate gyrus (P = .050), uncinate fasciculus (P = .029), superior longitudinal fasciculus (P = .020), or corpus callosum (P < .045). CONCLUSIONS: DTI characteristics of white matter regions reflect clinical improvement after shunt surgery in patients with iNPH. They tend to improve toward physiologic DTI values, thus further accentuating the benefit of shunt surgery in both clinical and radiologic pictures. Graphical Abstract


  • Predictors of postoperative complications and functional outcomes in pediatric patients with surgically treated fourth ventricle tumors

    by Kryštof Haratek, Adéla Bubeníková, Christian Joachim Entenmann, Martin Tomášek, Michal Zápotocký, David Sumerauer, Martin Kynčl, Miroslav Koblížek, Petr Libý, Michal Tichý, et al.

    Background Tumors of the fourth ventricle are frequently treated pathologies in pediatric neurosurgery. Data regarding predictors for permanent neurological deficits, long-term functional outcomes, cerebellar mutism (CM), the extent of resection (EOR), and oncological outcomes are scarce. We attempt to contribute to this topic with an analysis of our institutional cohort. Methods A retrospective single-center study of patients aged ≤ 19 years who underwent primary surgical resection of a fourth ventricular tumor over a 15-year period (2006–2021). Predictors analyzed included age, gender, surgical approach, anatomical pattern, tumor grade, EOR, tumor volume, and others as appropriate. Results One hundred six patients were included (64 males, mean age 7.3 years). The rate of permanent neurological deficit was 24.2%; lateral tumor extension (p = 0.036) and tumor volume greater than 38 cm3 (p = 0.020) were significant predictors. The presence of a deficit was the only significant predictor of reduced (less than 90) Lansky score (p = 0.005). CM occurred in 20.8% of patients and was influenced by medulloblastoma histology (p = 0.011), lateral tumor extension (p = 0.017), and male gender (p = 0.021). No significant difference between the transvermian and telovelar approach in the development of CM was detected (p = 0.478). No significant predictor was found for the EOR. EOR was not found to be a significant predictor of overall survival for both low-grade and high-grade tumors; however, gross total resection (GTR) was protective against tumor recurrence compared to near-total or subtotal resection (p < 0.001). In addition, survival was found to be better in older patients (≥ 7.0 years, p = 0.019). Conclusion The overall rate of postoperative complications remains high due to the eloquent localization. Older patients (> 7 years) have been found to have better outcomes and prognosis. Achieving GTR whenever feasible and safe has been shown to be critical for tumor recurrence. CM was more common in patients with medulloblastoma and in patients with tumors extending through the foramen of Luschka. The telovelar approach uses a safe and anatomically sparing corridor; however, it has not been associated with a lower incidence of CM and neurological sequelae in our series, showing that each case should be assessed on an individual basis.